Inflammation targets specific organs for cancer in carriers of BRCA1/2 pathway mutations [PDF]
Women who inherit a defective BRCA1 or BRCA2 gene have risks for breast/ovarian cancer that are so high and apparently so selective that many mutation carriers choose to have the most likely targets for cancer surgically removed.
Bernard Friedenson
core +1 more source
Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response [PDF]
Background:Understanding the factors that drive recurrence and radiosensitivity in brain metastases would improve prediction of outcomes, treatment planning and development of therapeutics.
Brodbelt, A +8 more
core +1 more source
Mild mutations in BRCA2 (FANCD1) cause Fanconi anemia (FA) when homozygous, while severe mutations cause common cancers including breast, ovarian, and prostate cancers when heterozygous.
BreMiller, Ruth A. +13 more
core +2 more sources
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. [PDF]
Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk.
Aalfs, Cora M +99 more
core
Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation [PDF]
Digweed, M. +8 more
core +1 more source
A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing [PDF]
core +1 more source
Fanconi Anemia complementation group C protein in metabolic disorders. [PDF]
Nepal M, Ma C, Xie G, Jia W, Fei P.
europepmc +1 more source
The Fanconi anemia pathway and ubiquitin [PDF]
Céline Jacquemont, Toshiyasu Taniguchi
core +1 more source
Advances in the understanding of Fanconi Anemia Complementation Group D2 Protein (FANCD2) in human cancer. [PDF]
Shen Y, Zhang J, Yu H, Fei P.
europepmc +1 more source

